Ran Svirsky

Dr. Ran Svirsky


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2015 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
JTJ. Tovbin
J. Tovbin
YMY. Melcer
Y. Melcer
SSS. Shor
S. Shor
MPM. Pekar‐Zlotin
M. Pekar‐Zlotin
SMS. Mendlovic
S. Mendlovic
RMR. Maymon
R. Maymon
Objective: To evaluate the accuracy of an ultrasound‐based scoring system for diagnosing morbidly adherent placenta (MAP).Methods: This study included pregnant women referred to our ultrasound unit during 2013–2015 because of suspected MAP on a previous ultrasound examination or because they had at least one previous Cesarean delivery. All women were assessed using a scoring system based on the following: number and size of placental lacunae; obliteration of the demarcation between the uterus and placenta; placental location; color Doppler signals within placental lacunae; hypervascularity of the placenta–bladder and/or uteroplacental interface zone; and number of previous Cesarean deliveries. Each criterion was assigned 0, 1 or 2 points and the sum of points yielded the final score. Patients were classified into low, moderate or high probability for MAP based on the final score. The presence of MAP was determined by the surgeon at delivery and clinical descriptions were documented in the electronic patient file. Pathological diagnoses were available only in cases that underwent hysterectomy.Results: In total, 258 pregnant women were included in the study, of whom 23 (8.9%) were diagnosed with MAP. There was a statistically significant difference in the prevalence of MAP when women were grouped according to the scoring system, with 0.9%, 29.4% and 84.2% in the low, moderate and high probability groups, respectively (P < 0.0001). All sonographic criteria of the scoring system were significantly associated with MAP (P < 0.0001). Receiver–operating characteristics (ROC) curves for prediction of MAP using the number of placental lacunae and obliteration of the uteroplacental demarcation yielded an area under the ROC curve of 0.94 (95% CI, 0.86–1.00).Conclusions: Our proposed scoring system is highly predictive of MAP in patients at risk. This allows an adequate multidisciplinary team approach for the planning and timing of delivery in such cases. Copyright © 2015 ISUOG. Published by John Wiley & Sons Ltd.

1 August 2008 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
RSRan Svirsky
Ran Svirsky
NSNoam Smorgick
Noam Smorgick
URUri Rozowski
Uri Rozowski
RSRon Sagiv
Ron Sagiv
MFMichal Feingold
Michal Feingold
MPMoty Pansky
Moty Pansky

1 September 2011 in Journal of Ultrasound in Medicine
Verified
Journal Article
Closed access
PDF file
RMRon Maymon
Ron Maymon
RSRan Svirsky
Ran Svirsky
NSNoam Smorgick
Noam Smorgick
SMSonia Mendlovic
Sonia Mendlovic
RHReuvit Halperin
Reuvit Halperin
YTYosef Tobvin
Yosef Tobvin

1 January 2009 in Reproductive Toxicology
Verified
Journal Article
Closed access
RSRan Svirsky
Ran Svirsky
URUri Rozovski
Uri Rozovski
ZVZvi Vaknin
Zvi Vaknin
MPMoty Pansky
Moty Pansky
DSDavid Schneider
David Schneider
RHReuvit Halperin
Reuvit Halperin

1 November 2013 in Obstetrical & Gynecological Survey
Verified
Journal Article
Closed access
IBIdo Ben-Ami
Ido Ben-Ami
RMRon Maymon
Ron Maymon
RSRan Svirsky
Ran Svirsky
HCHoward Cuckle
Howard Cuckle
EJEric Jauniaux
Eric Jauniaux
The objective of this study was to provide a critical analysis of the impact of assisted conception on prenatal screening for Down syndrome (DS) in twin pregnancies and the value of various screening modalities for early detection of anomalies. The literature was searched using PubMed and the Cochrane Library focusing on prenatal screening and antenatal care of assisted-conception twin pregnancies. Serum screening alone is of limited value in detecting aneuploid twins, because the unaffected cotwin can “mask” the abnormal serum results of an affected one. In addition, this test can designate the pregnancy as at high risk but not identify the affected fetus. Nuchal translucency (NT) screening is the best available modality and a highly effective screening method for twin pregnancies. Among twins, NT alone has a 69% DS detection rate, first-trimester combined NT and serum biochemistry has a 72% DS detection rate, and an integrated screen will have an 80% DS detection rate at a 5% FPR. The data in the literature concerning the effect of assisted conception on maternal serum screening markers in twin pregnancies are scarce. Down syndrome screening in assisted-conception twins presents clinical and technical challenges. Therefore, assisted-conception twins need close monitoring from conception to delivery, by a practitioner familiar with the available screening modalities and their relative accuracy. Target Audience: Obstetricians and gynecologists, family physicians Learning Objectives: After completing this CME activity, physicians should be better able to identify the problems associated with prenatal diagnosis of Down syndrome in twins in general, and in assisted reproduction technology–conceived twins in particular, and perform the screening tests for spontaneous and assisted reproduction technology–conceived twin pregnancies, including identifying their diagnostic accuracy and pitfalls.

6 May 2014 in Prenatal Diagnosis
Verified
Journal Article
Closed access
PDF file
RSRan Svirsky
Ran Svirsky
SYS. Yagel
S. Yagel
IBI. Ben‐Ami
I. Ben‐Ami
HCH. Cuckle
H. Cuckle
EKE. Klug
E. Klug
RMR. Maymon
R. Maymon